Literature DB >> 29588847

Impact and cost-effectiveness of formal gastroenterology outpatient referral Clinical Assessment Service.

Stavroula Pelitari1, Charlotte Hathaway1, Dean Gritton1, Andrea Smith2, David Bush2, Shyam Menon1, Brian McKaig1.   

Abstract

OBJECTIVE: The aim was to assess the financial and operational impact of our new gastroenterology referral pathway model on our services.
DESIGN: An electronic 'Clinical Assessment Service' (CAS) proforma and an information platform were developed, and all data were analysed retrospectively.
SETTING: Royal Wolverhampton NHS Trust. PATIENTS: 14 245 general practitioner (GP) referrals were received during January 2014-December 2016 with 9773 of them being triaged via our CAS. MAIN OUTCOME MEASURES: We looked into patients' clinical outcome along with departmental performance and finances.
RESULTS: A new outpatient appointment was offered to 60.1% (n=5873) of the CAS referred patients. Endoscopic or radiological investigations were requested for 29.2% (n=2854) of patients prior to deciding on further management plan. Out of those, 27% (n=765) went on to receive another gastroenterology (GI) clinic appointment. The remaining 21.3% (n=2089) of the CAS patients were discharged back to their GP following initial investigations. 5.5% (n=538) were discharged back to primary care with a letter of advice, whereas 5.2% (n=509) were deemed inappropriate for GI clinic and were redirected to other specialists. Overall, 32% (n=3127) of patients were managed without a face to face consultation in the GI clinic. This corresponds to 3136 less outpatient appointments with estimated reduced expenditure by the Clinical Commissioning Group (CCG) of £481K. The 18-week performance and waiting times remained stable despite the increasing referral population. The DNA rate dropped from 14% pre to 8.5%.
CONCLUSIONS: Our clinical assessment model has, in addition to the clinical benefits, a considerable positive financial impact to the health economy.

Entities:  

Keywords:  clinical decision making

Year:  2017        PMID: 29588847      PMCID: PMC5868438          DOI: 10.1136/flgastro-2017-100853

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  5 in total

1.  Trends in physician referrals in the United States, 1999-2009.

Authors:  Michael L Barnett; Zirui Song; Bruce E Landon
Journal:  Arch Intern Med       Date:  2012-01-23

2.  Improving referral activity on primary-secondary care interface using an electronic decision support system.

Authors:  Giuliano Mariotti; Maria Gentilini; Valter Dapor
Journal:  Int J Med Inform       Date:  2013-08-15       Impact factor: 4.046

3.  Referral management schemes: good for whom?

Authors:  Gareth Iacobucci
Journal:  BMJ       Date:  2017-01-04

4.  Impact of the United Kingdom national bowel cancer awareness campaigns 2012 on colorectal cancer services and patient survival.

Authors:  T L Khong; K Naik; R Sivakumar; S Shah
Journal:  Colorectal Dis       Date:  2015-12       Impact factor: 3.788

5.  Optimizing the pre-referral workup for gastroenterology and hepatology specialty care: consensus using the Delphi method.

Authors:  Chanda K Ho; Christy K Boscardin; Nathaniel Gleason; Don Collado; Jonathan Terdiman; Norah A Terrault; Ralph Gonzales
Journal:  J Eval Clin Pract       Date:  2015-07-30       Impact factor: 2.431

  5 in total
  3 in total

1.  Improving medical consults for surgical inpatients: a quality improvement project using an e-referral system linked to clinical pathways.

Authors:  Mahmoud Amer; Prosen Ghosh; Animesh Chatterjee
Journal:  BMJ Open Qual       Date:  2022-06

Review 2.  COVID-19: Effect on gastroenterology and hepatology service provision and training: Lessons learnt and planning for the future.

Authors:  Muhammad Raheel Anjum; Jodie Chalmers; Rizwana Hamid; Neil Rajoriya
Journal:  World J Gastroenterol       Date:  2021-11-28       Impact factor: 5.742

3.  Challenges and opportunities of COVID-19 for gastroenterology and hepatology services.

Authors:  Tony C Tham; Andrew C Douds; Rupert Ransford
Journal:  Frontline Gastroenterol       Date:  2020-09-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.